Beyond Synergy: Unanswered Questions and Critical Reflections on AI-Assisted Colonoscopy Efficacy?
APA
Guo Z, Guo J, et al. (2026). Beyond Synergy: Unanswered Questions and Critical Reflections on AI-Assisted Colonoscopy Efficacy?. Journal of gastroenterology and hepatology, 41(3), 1077-1078. https://doi.org/10.1111/jgh.70241
MLA
Guo Z, et al.. "Beyond Synergy: Unanswered Questions and Critical Reflections on AI-Assisted Colonoscopy Efficacy?." Journal of gastroenterology and hepatology, vol. 41, no. 3, 2026, pp. 1077-1078.
PMID
41540786
같은 제1저자의 인용 많은 논문 (5)
- Discovery of novel and potent 2-aminopyrazine-based HPK1 inhibitors enhancing T-cell immunity against cancer.
- RASGEF1B suppresses hepatocellular carcinoma through the ALDH7A1/Betaine/SNAI1 metabolic‒epigenetic axis.
- Mitochondria Pathway Signature Predicts Prognosis and Therapeutic Response and Identifies REXO2 as a Crucial Regulator in Breast Cancer.
- The microbial metabolite I3A inhibits ferroptosis and the effectiveness of redox-based cancer therapy.
- Correction: Guo et al. Shikonin as a WT1 Inhibitor Promotes Promyeloid Leukemia Cell Differentiation. 2022, , 8264.